<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
  <channel>
    <title>Protein Design Labs Inc — New Patents | PatentBrief</title>
    <link>https://patentbrief.org/company/protein-design-labs-inc</link>
    <description>Plain-English explanations of patents assigned to Protein Design Labs Inc, newest first.</description>
    <language>en-us</language>
    <lastBuildDate>Mon, 15 Jun 2026 06:02:08 GMT</lastBuildDate>
    <atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://patentbrief.org/company/protein-design-labs-inc/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>How Scientists Create Human-Friendly Antibodies for Medicine</title>
      <link>https://patentbrief.org/patent/us/5585089/remicade-infliximab</link>
      <description>This patent describes a method for modifying mouse antibodies so human immune systems accept them as their own, allowing them to be used as powerful, long-lasting medical treatments.</description>
      <pubDate>Tue, 17 Dec 1996 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://patentbrief.org/patent/us/5585089/remicade-infliximab</guid>
    </item>
  </channel>
</rss>
